Last month we wrote an article entitled: Guidelines for Dispensing Insulin Pens in their Original Carton. A few days later, the Office of Inspector General (OIG) announced that CVS had agreed to a $37.76 million settlement for violations of the False Claims Act by over-dispensing insulin pens between 2010 and 2020. Investigators found that Medicare, Medicaid, TRICARE, and the Federal Employees Health Benefits Program made significant overpayments for these prescriptions.
The overpayments stemmed from CVS pharmacies submitting incorrect days’ supply information, which allowed claims to be refilled earlier than appropriate. Updated package instructions promote dispensing insulin pens in their original carton, whereby the amount of insulin in a full box often exceeds plan limits. CVS pharmacies billed inaccurate days’ supplies and then refilled prescriptions before meeting the appropriate utilization threshold.
PAAS National® first notified members via email alert in January 2019, followed by a Newsline article in March 2019 titled, Breaking Insulin Boxes—Your Questions Answered, after the OIG announced a $269.2 million civil healthcare fraud settlement with Walgreens. The primary issue in this settlement involved the overpayments of insulin pens.
Automatic refill programs were a major contributor to this over-dispensing. Many patients received insulin far earlier than needed because pharmacies utilized the submitted days’ supply rather than the actual days’ supply. Since third-party payors can only reject early refills when an accurate days’ supply is reported, their ability to prevent inappropriate refills was “limited”.
Do not let your pharmacy fall into this same situation. Stay vigilant by ensuring your staff is trained to bill correctly when the smallest package size exceeds a plan limit. Utilize the automatic refill programs appropriately and safeguard your claims from audit recoupment and further scrutiny.
PAAS Tips:
Become an audit assistance member today to continue reading this article. As a member, you’ll have access to hundreds of articles and receive our monthly proactive newsletter!
Did you know there is much more to your audit assistance membership than just help with audits? The PAAS Member Portal contains a wealth of information and resources to assist you with audits and member service questions. Below is a list of 6 pages found on the Audit Assistance section of the PAAS Member Portal to assist you and your pharmacy staff to be proactive when it comes to audits.
- Access Services
- Audit Documentation Submission Guidance
- An online form to submit safe filling and billing questions
- Your PAAS Membership Manual
- Newsline
- Monthly newsletter articles, written by our expert PAAS analyst team, provide safe filling and billing tips and relays relevant/current PBM trends to be help prevent audits
- Search the Newsline Archive to get PAAS tips at the click of a button
- Special Edition Newslines including: Top 10 articles of the prior year, DMEPOS Article Series and a Self-Audit Article Series
- Ability to print monthly issues or individual articles
- Proactive Tips
- Audit flags – list of various claim attributes the PBMs use to select claims for audit
- Billing insulin vials – flowchart to assist whether you should bill Medicare Part B vs Part D
- DAW Codes Explained – use to understand when to effectively use DAW codes, their definitions and why claims may be flagged for audit if a DAW code is used incorrectly
- Basic DMEPOS documentation guidance
- Onsite Credentialing Checklist and expanded definitions of policies and procedures
- Proof of refill request and affirmative response form for DMEPOS items
- Steps on how to prepare for an onsite audit
- And more!
- Days’ Supply Charts
- Utilize the days’ supply charts for inhalers, insulins, nasal sprays, eye drops and topicals to aid you in calculating the correct days’ supply
- Guidance on overbilled quantities and incorrect days’ supply account for a sizable portion of audit chargebacks
- Additional miscellaneous charts, which include: Dispense in Original Container and Return to Stock
- Forms
- Signature Logbook for print
- Signature Trifold Mailer
- Fax and Email Coversheet
- Patient Attestation for over-the-counter COVID-19 test kits
- On-Demand Webinars
- Short webinars on hot topics in the PBM industry. Here are a few examples:
- USP 800 Compliance
- Cultural Competency Training
- Dispensing Prescriptions Off-Label
- Biologic Medications and Interchangeability
- Continuous Glucose Monitor Requirements for Medicare Part B
PAAS Tips:
- MORE AUDITS, MORE INSIGHT – PAAS National® is the industry-leading defender of community pharmacy dealings with Prescription Benefit Programs, including Caremark, Express Scripts, Humana, Medicaid, OptumRx, Prime Therapeutics., and more. PAAS assists on all third-party audits, including: desktop audits, onsite audits, invoice audits, OIG/Medicaid audits, Medicare B audits. The PAAS team is dedicated to helping you! We have five pharmacists and a complement of technician analysts with over 50 years of dedicated audit assistance experience. PAAS continuously updates their database with every audit received — in fact, we even keep a scorecard on individual auditors.
- Get answers to your questions on days’ supply calculations, drug substitutions, billing practices, required documentation, prior authorization requirements, record retention, and internal audit procedures – just to name a few. As a trusted partner, we will provide tailored guidance to help you proactively prevent audits. Remember, the prescription claims you submit today are the audits of the future.
- Keep your employees engaged and help lower audit risk by adding all employees to the portal and giving them permission to access these tools, resources and eNewsline. For more information review September 2019 Newsline article, What Are You Waiting For? Make Sure ALL of Your Employees are Added to the PAAS Portal!
- Contact PAAS at (608) 873-1342, if you would like a tour of your PAAS Member Portal, so you can reap all the benefits of your PAAS Audit Assistance. We appreciate you being a member.
340B Claim Identification Requirements
As part of the NCPA 340B task force, PAAS National®® has advocated strongly that pharmacies should not be required to identify 340B claims. The individual claim’s status is typically unknown at the point of sale, and the process to update claims (N1 information exchange transactions), or reverse and rebill, is arduous. Not only is it more labor intensive, but it’s also a matter of timing when product is replenished.
However, pharmacies participating in 340B should be aware of the claim identification requirements, as stated in the various PBM Provider Manuals. Consider the following…
Did you know there is much more to your audit assistance membership than just help with audits? The PAAS Member Portal contains a wealth of information and resources to assist you with audits and member service questions. Below is a list of 6 pages found on the Audit Assistance section of the PAAS Member Portal to assist you and your pharmacy staff to be proactive when it comes to audits.
PAAS Tips:
Caremark Rx Claim Review – Is This Trouble for My Pharmacy?
Pharmacies have sent PAAS National® notices from Caremark entitled “CVS Caremark Rx Claim Review.” The first line of the notice says, “This communication is for educational purposes only and is not part of an audit.” This has led to many questions and confusion amongst the pharmacies receiving these notices. PAAS has seen waves of these letters over the years. The medications targeted have changed over time, but the wording is nearly the same.
Did you know there is much more to your audit assistance membership than just help with audits? The PAAS Member Portal contains a wealth of information and resources to assist you with audits and member service questions. Below is a list of 6 pages found on the Audit Assistance section of the PAAS Member Portal to assist you and your pharmacy staff to be proactive when it comes to audits.
PAAS Tips:
New Year, Same Routine: Tips for Ensuring Accurate Billing
For pharmacies, the new year is often hectic. PAAS National®® is here to help make your transition into the new year less stressful by highlighting important billing considerations and tips.
Did you know there is much more to your audit assistance membership than just help with audits? The PAAS Member Portal contains a wealth of information and resources to assist you with audits and member service questions. Below is a list of 6 pages found on the Audit Assistance section of the PAAS Member Portal to assist you and your pharmacy staff to be proactive when it comes to audits.
PAAS Tips:
OIG Report: Medicare Payments for Continuous Glucose Monitors
A recent OIG report found that Medicare may be overpaying suppliers for Continuous Glucose Monitors (CGMs) and supplies relative to other payers.
The report highlighted the following:
As a result of the findings, OIG has recommended that CMS reduce payments for CGMs and supplies and address improper use of billing codes to reduce overpayments.
CMS has included Class 2 CGMs and supplies in the next round of the DMEPOS Competitive Bidding Program as per Final Rule (CMS-1828-F) published December 2, 2025 which would both reduce prices and limit the number of suppliers eligible to bill for CGMs and related supplies. This process is expected to begin in 2026 and be completed no later than January 1, 2028. Previous rounds of competitive bidding yielded an average savings of 35% relative to the fee schedule prices.
The DMEPOS MAC for Jurisdictions B and C have posted the Medical Review Quarterly Reports for Targeted, Probe, and Educate (TPE) audits covering July to September 2025 and found that Glucose Monitors & Supplies have an 18.52% error rate overall and provides the top 10 denial reasons.
PAAS Tips:
Did you know there is much more to your audit assistance membership than just help with audits? The PAAS Member Portal contains a wealth of information and resources to assist you with audits and member service questions. Below is a list of 6 pages found on the Audit Assistance section of the PAAS Member Portal to assist you and your pharmacy staff to be proactive when it comes to audits.
PAAS Tips:
$37.76 Million CVS Insulin Pen Case Settled
Last month we wrote an article entitled: Guidelines for Dispensing Insulin Pens in their Original Carton. A few days later, the Office of Inspector General (OIG) announced that CVS had agreed to a $37.76 million settlement for violations of the False Claims Act by over-dispensing insulin pens between 2010 and 2020. Investigators found that Medicare, Medicaid, TRICARE, and the Federal Employees Health Benefits Program made significant overpayments for these prescriptions.
The overpayments stemmed from CVS pharmacies submitting incorrect days’ supply information, which allowed claims to be refilled earlier than appropriate. Updated package instructions promote dispensing insulin pens in their original carton, whereby the amount of insulin in a full box often exceeds plan limits. CVS pharmacies billed inaccurate days’ supplies and then refilled prescriptions before meeting the appropriate utilization threshold.
PAAS National® first notified members via email alert in January 2019, followed by a Newsline article in March 2019 titled, Breaking Insulin Boxes—Your Questions Answered, after the OIG announced a $269.2 million civil healthcare fraud settlement with Walgreens. The primary issue in this settlement involved the overpayments of insulin pens.
Automatic refill programs were a major contributor to this over-dispensing. Many patients received insulin far earlier than needed because pharmacies utilized the submitted days’ supply rather than the actual days’ supply. Since third-party payors can only reject early refills when an accurate days’ supply is reported, their ability to prevent inappropriate refills was “limited”.
Do not let your pharmacy fall into this same situation. Stay vigilant by ensuring your staff is trained to bill correctly when the smallest package size exceeds a plan limit. Utilize the automatic refill programs appropriately and safeguard your claims from audit recoupment and further scrutiny.
PAAS Tips:
Did you know there is much more to your audit assistance membership than just help with audits? The PAAS Member Portal contains a wealth of information and resources to assist you with audits and member service questions. Below is a list of 6 pages found on the Audit Assistance section of the PAAS Member Portal to assist you and your pharmacy staff to be proactive when it comes to audits.
PAAS Tips:
Eye Drop Chart Updates
PAAS National® analysts have identified a recent trend of audit enforcement related to days’ supply for eye drops, with a particular focus from Prime Therapeutics. Most PBMs provide a “drops per mL” estimate in their provider manual, but they often provide a qualifier that pharmacies should use the PBM estimate “unless otherwise indicated by the manufacturer”.
Recently, Prime Therapeutics has…
Did you know there is much more to your audit assistance membership than just help with audits? The PAAS Member Portal contains a wealth of information and resources to assist you with audits and member service questions. Below is a list of 6 pages found on the Audit Assistance section of the PAAS Member Portal to assist you and your pharmacy staff to be proactive when it comes to audits.
PAAS Tips:
Splitting Suboxone® Can Lead to Audit Recoupments
PAAS National® has noticed an uptick in audit recoupments for Suboxone® claims where the patient instructions were to split the films or tablets. Notably, OptumRx has a renewed focused on these claims and has been citing them as…
Did you know there is much more to your audit assistance membership than just help with audits? The PAAS Member Portal contains a wealth of information and resources to assist you with audits and member service questions. Below is a list of 6 pages found on the Audit Assistance section of the PAAS Member Portal to assist you and your pharmacy staff to be proactive when it comes to audits.
PAAS Tips:
2026 PAAS Fraud, Waste & Abuse and HIPAA Compliance Program Updates
PAAS National® continuously monitors legislative and regulatory changes that may impact your Fraud, Waste & Abuse and HIPAA Compliance Program. We keep a close eye on enforcement from the Department of Justice, Office of Inspector General, State Attorney Generals, and Office for Civil Rights to help ensure the program meets interpretative standards. Furthermore, PAAS works to keep pace with Pharmacy Benefit Managers as they continue to add credentialing requirements that can be extremely difficult, and a significant nuisance, to independent pharmacies.
PAAS has implemented changes to ensure pharmacies continue to have a robust program in place. PAAS FWA/HIPAA compliance program members can login to the member portal to view the 2026 FWAC and HIPAA Updates. This year’s updates included:
Administrators should review all Compliance Tasks (located in the left-hand navigation on the PAAS Member Portal) at least annually to keep the program up-to-date and in compliance. Section 2.6 Updates of Policies and Procedures of your manual contains information on maintaining open lines of communication and the distribution of changes.
If you’re not a member of PAAS’ FWA/HIPAA compliance program, contact us today to add the program for a discounted rate!
The Audit Risk at The Tips of Your Fingers (and Toes!)
Antifungal nail treatments remain a high audit target. If the pharmacy is dispensing Jublia® (efinaconazole), ciclopirox (formerly Penlac®), or tavaborole (formerly Kerydin®), you can almost guarantee you’ll see that claim show up on an audit. Auditors love these medications because if the prescription does not clearly indicate…
Did you know there is much more to your audit assistance membership than just help with audits? The PAAS Member Portal contains a wealth of information and resources to assist you with audits and member service questions. Below is a list of 6 pages found on the Audit Assistance section of the PAAS Member Portal to assist you and your pharmacy staff to be proactive when it comes to audits.
PAAS Tips:
2025 PBM Prescription Validation Requests Summary
PAAS National® saw the number of validation requests/claim reviews increase 22% in 2025. While OptumRx® sends out most of the validation requests/claim reviews, we also see them from Caremark, Express Scripts, Humana, MagellanRx, Medimpact, and Prime Therapeutics. Three additional PBMs began to do the reviews in 2025 and those are Meridian, Pharmastar and some Medicaid plans.
Below is a comparison of the top 5 drugs reviewed in 2025 versus 2024.
Did you know there is much more to your audit assistance membership than just help with audits? The PAAS Member Portal contains a wealth of information and resources to assist you with audits and member service questions. Below is a list of 6 pages found on the Audit Assistance section of the PAAS Member Portal to assist you and your pharmacy staff to be proactive when it comes to audits.
PAAS Tips: